Correlation Between Mosaic Immunoengineerin and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mosaic Immunoengineerin and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mosaic Immunoengineerin and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mosaic Immunoengineering and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Mosaic Immunoengineerin and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mosaic Immunoengineerin with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mosaic Immunoengineerin and Fennec Pharmaceuticals.
Diversification Opportunities for Mosaic Immunoengineerin and Fennec Pharmaceuticals
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mosaic and Fennec is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Mosaic Immunoengineering and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Mosaic Immunoengineerin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mosaic Immunoengineering are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Mosaic Immunoengineerin i.e., Mosaic Immunoengineerin and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mosaic Immunoengineerin and Fennec Pharmaceuticals
Given the investment horizon of 90 days Mosaic Immunoengineering is expected to generate 9.72 times more return on investment than Fennec Pharmaceuticals. However, Mosaic Immunoengineerin is 9.72 times more volatile than Fennec Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 70.00 in Mosaic Immunoengineering on October 25, 2024 and sell it today you would earn a total of 28.00 from holding Mosaic Immunoengineering or generate 40.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mosaic Immunoengineering vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Mosaic Immunoengineering |
| Fennec Pharmaceuticals |
Mosaic Immunoengineerin and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mosaic Immunoengineerin and Fennec Pharmaceuticals
The main advantage of trading using opposite Mosaic Immunoengineerin and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mosaic Immunoengineerin position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Mosaic Immunoengineerin vs. Cell Source | Mosaic Immunoengineerin vs. Marizyme | Mosaic Immunoengineerin vs. ACRO Biomedical Co |
| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |